Remission as a new therapeutic goal

A paradigm shift is emerging in the management of asthma, where the aim is not only asthma control but also remission. It has been shown that this ambitious goal can be achieved with highly effective anti-inflammatory drugs that are available today. The determination of type 2 markers is of great importance in this therapy concept. The aim is to implement the individually appropriate therapy as early as possible in the course of the disease.